ES2146240T3 - Agente inmunomodulador y antiinflamatorio. - Google Patents
Agente inmunomodulador y antiinflamatorio.Info
- Publication number
- ES2146240T3 ES2146240T3 ES94112427T ES94112427T ES2146240T3 ES 2146240 T3 ES2146240 T3 ES 2146240T3 ES 94112427 T ES94112427 T ES 94112427T ES 94112427 T ES94112427 T ES 94112427T ES 2146240 T3 ES2146240 T3 ES 2146240T3
- Authority
- ES
- Spain
- Prior art keywords
- agent
- diseases
- pharmaceutical composition
- immunomodulating
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCION PREVE UNA COMPOSICION FARMACEUTICA CON UN NUEVO UNOS FARMACEUTICO QUE CONTIENE UNA GLOBULINA GAMA AÑADIDA DE HISTAINA COMO COMPONENTE EFECTIVO. LA INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONTIENE UNA GLOBULINA DE GAMA AÑADIDA DE HISTAMINA USADA COMO UN AGENTE DE INMUNOMODULACION, COMO, UN AGENTE SUPRESOR PARA EOSINOFILIO Y AGENTE ANTIINFLAMATORIO, ETC. LA COMPOSICION FARMACEUTICA DE LA PRESENTE INVENCION TIENE UNA ACCION INMUNOMODULADORA QUE ES CLARAMENTE DIFERENTE DE LOS AGENTES INMUNOSUPRESOES CONVENCIONALES. DE ACUERDO, DON DICHA COMPOSICION ES UTIL COMO AGENTE FARMACEUTICO PARA LA TERAPIA DE LAS ENFERMEDADES CON SISTEMA INMUNOLOGICO ANORMAL TAL COMO, POR EJEMPLO REUMATISMO ARTICULAR CRONICO, ERITEMATOSIS DE LUPUS SISTEMICA, ESCLEROSIS MULTIPLE, ETC Y VARIOS TIPOS DE SINDROMES DE INMUNODEFICIENCIA. ADEMAS, LA COMPOSICION FARMACEUTICA DE LA PRESENTE INVENCION TAMBIEN MUESTRA UNA ACCION SUPRESOR SOBRE UNA HIPEREOSOFILIDAD Y PUEDE USARSE COMO UN AGENTETERAPEUTICO PARA ENFERMEDADES INFECCIOSAS, ENFERMEDADES PARASITARIAS, ENFERMEDADES RESPIRATORIAS, ENFERMEDADES AUTOINMUNE Y EOSINOFILIA CAUSADA POR TUMOR MALIGNO, ASI COMO UN AGENTE ANTIINFLAMATORIO EN EL QUE DICHA COMPOSICION ES MUY UTIL.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21804393A JP3193205B2 (ja) | 1993-08-09 | 1993-08-09 | 好酸球増多抑制剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2146240T3 true ES2146240T3 (es) | 2000-08-01 |
Family
ID=16713756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94112427T Expired - Lifetime ES2146240T3 (es) | 1993-08-09 | 1994-08-09 | Agente inmunomodulador y antiinflamatorio. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5780026A (es) |
| EP (1) | EP0646376B1 (es) |
| JP (1) | JP3193205B2 (es) |
| KR (1) | KR100275174B1 (es) |
| CN (3) | CN1127983C (es) |
| AT (1) | ATE192655T1 (es) |
| DE (1) | DE69424362T2 (es) |
| ES (1) | ES2146240T3 (es) |
| TW (1) | TW258664B (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6566386B2 (en) | 1993-08-09 | 2003-05-20 | Nippon Zoki Pharmaceutical Co., Ltd. | Immunomodulating and antiinflammatory agent |
| JP3193205B2 (ja) * | 1993-08-09 | 2001-07-30 | 日本臓器製薬株式会社 | 好酸球増多抑制剤 |
| IT1278052B1 (it) * | 1995-03-14 | 1997-11-17 | Mendes Srl | Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US6562629B1 (en) | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
| JPH0959180A (ja) * | 1995-08-11 | 1997-03-04 | Nippon Zoki Pharmaceut Co Ltd | 活性化免疫グロブリン |
| US5961969A (en) * | 1996-05-14 | 1999-10-05 | Maxim Pharmaceuticals, Inc. | Stable circulating histamine levels |
| US6071942A (en) | 1996-05-14 | 2000-06-06 | Maxim Pharmaceuticals, Inc. | Elevation of circulating blood histamine levels |
| JPH10212246A (ja) | 1997-01-30 | 1998-08-11 | Nippon Zoki Pharmaceut Co Ltd | 経口投与用製剤 |
| US7232830B2 (en) | 1998-06-26 | 2007-06-19 | Elaine A Delack | Method for treatment of neurodegenerative diseases and effects of aging |
| JP2000143537A (ja) * | 1998-11-13 | 2000-05-23 | Nippon Zoki Pharmaceut Co Ltd | 細胞接着分子発現抑制剤 |
| JP2000143536A (ja) * | 1998-11-13 | 2000-05-23 | Nippon Zoki Pharmaceut Co Ltd | 抗浮腫剤 |
| US6242473B1 (en) * | 1999-01-08 | 2001-06-05 | Maxim Pharmaceuticals, Inc. | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| DE19944122A1 (de) * | 1999-09-15 | 2001-03-29 | Wolfgang Loh | Histamin-Immunglobulin-Komplexe zur Behandlung von entzündlichen Erkrankungen bei Säugetieren |
| EP2147679B1 (en) | 2001-07-25 | 2014-06-25 | Raptor Pharmaceutical, Inc. | Compositions for blood-brain barrier transport |
| WO2004075845A2 (en) * | 2003-02-24 | 2004-09-10 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for treating or preventing autoimmune disease using histamine h1 receptor-blocking agents |
| DK1889198T3 (da) | 2005-04-28 | 2015-02-09 | Proteus Digital Health Inc | Farma-informatiksystem |
| WO2008036682A2 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
| US8163308B2 (en) | 2007-05-10 | 2012-04-24 | Rajesh Shah | Homeopathy-based formulation |
| DK2398500T3 (da) | 2009-02-20 | 2019-05-13 | 2 Bbb Medicines B V | Glutathion-baseret lægemiddelafgivelsessystem |
| IL255113B (en) | 2009-05-06 | 2022-09-01 | Laboratory Skin Care Inc | Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5585526A (en) * | 1978-12-23 | 1980-06-27 | Nippon Zoki Pharmaceut Co Ltd | Remedy for allergic disease |
| US4705685A (en) * | 1982-05-17 | 1987-11-10 | Mcmichael John | Methods and materials for treatment of disease states involving immunological factors |
| US4704273A (en) * | 1982-05-17 | 1987-11-03 | Mcmichael John | Methods and materials for treatment of rheumatoid arthritis |
| US4705687A (en) * | 1985-06-17 | 1987-11-10 | Ortho Pharmaceutical (Canada) Ltd. | Treatment of autoimmune diseases such as rheumatoid arthritis with suppressor factor |
| US5244902A (en) * | 1989-08-21 | 1993-09-14 | Beth Israel Hospital Association | Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| IT1237475B (it) * | 1989-10-06 | 1993-06-07 | Allergeni modificati chimicamente e procedimento per la loro preparazione | |
| US5192773A (en) * | 1990-07-02 | 1993-03-09 | Vertex Pharmaceuticals, Inc. | Immunosuppressive compounds |
| JP3193205B2 (ja) * | 1993-08-09 | 2001-07-30 | 日本臓器製薬株式会社 | 好酸球増多抑制剤 |
-
1993
- 1993-08-09 JP JP21804393A patent/JP3193205B2/ja not_active Expired - Fee Related
-
1994
- 1994-07-30 TW TW083106994A patent/TW258664B/zh active
- 1994-08-05 KR KR1019940019333A patent/KR100275174B1/ko not_active IP Right Cessation
- 1994-08-08 CN CN94109522A patent/CN1127983C/zh not_active Expired - Fee Related
- 1994-08-08 US US08/287,249 patent/US5780026A/en not_active Expired - Fee Related
- 1994-08-09 EP EP94112427A patent/EP0646376B1/en not_active Expired - Lifetime
- 1994-08-09 ES ES94112427T patent/ES2146240T3/es not_active Expired - Lifetime
- 1994-08-09 AT AT94112427T patent/ATE192655T1/de not_active IP Right Cessation
- 1994-08-09 DE DE69424362T patent/DE69424362T2/de not_active Expired - Fee Related
-
2001
- 2001-08-01 CN CNA011244771A patent/CN1471975A/zh active Pending
- 2001-08-01 CN CNA011244763A patent/CN1471974A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0646376A1 (en) | 1995-04-05 |
| CN1471975A (zh) | 2004-02-04 |
| ATE192655T1 (de) | 2000-05-15 |
| KR100275174B1 (ko) | 2000-12-15 |
| JPH0753406A (ja) | 1995-02-28 |
| JP3193205B2 (ja) | 2001-07-30 |
| DE69424362T2 (de) | 2000-10-19 |
| CN1471974A (zh) | 2004-02-04 |
| EP0646376B1 (en) | 2000-05-10 |
| DE69424362D1 (de) | 2000-06-15 |
| TW258664B (es) | 1995-10-01 |
| US5780026A (en) | 1998-07-14 |
| CN1121430A (zh) | 1996-05-01 |
| KR950005323A (ko) | 1995-03-20 |
| CN1127983C (zh) | 2003-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2146240T3 (es) | Agente inmunomodulador y antiinflamatorio. | |
| NL300224I1 (nl) | 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl-of indanylalkyla-minoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen. | |
| MY131458A (en) | Pyrolopyrimidine compounds | |
| ES8701496A1 (es) | Procedimiento para preparar una sal de 9-(1, 3-dihidroxi-2-propoximetil)-guanina farmaceuticamente aceptable | |
| PT705100E (pt) | Guanidinas substituidas terapeuticas | |
| IT7928417A0 (it) | Composizioni farmaceutiche con esaltazione dell'attivita'terapeutica di cortisonici. | |
| ES2157992T3 (es) | Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas. | |
| FR2401186A1 (fr) | Polyesters halogenes insatures, procede d'obtention et applications | |
| IT8009551A0 (it) | E-5-(2-alogenovinil-)-2'deossicitidine, loro metodo di preparazione e loro impiego per il trattamentodi malattie da virus | |
| IT1091051B (it) | Procedimento per l'estrusione ad alta riduzione di metalli | |
| NO932377L (no) | Antivirale forbindelser | |
| IL75805A (en) | Pharmaceutical immunosuppressor compositions containing lycorine | |
| BG93298A (bg) | Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни | |
| DE69813070D1 (de) | Pharmazeutische Zubereitung zur oralen Anwendung enthaltend einen Histamin-Immunoglobulin Komplex | |
| ATE49120T1 (de) | Entzuendungshemmende zusammensetzung. | |
| IL110187A0 (en) | 10-Substituted 1,8-dihydroxy-9(10H) anthracenones and pharmaceutical compositions containing them | |
| DE3769287D1 (de) | Heilmittel gegen leishmaniose. | |
| IL56442A (en) | Solvent vehicle for the parenteral administration of therapeutics containing an adipic acid ester,pharmaceutical compositions comprising said vehicle and their use in the prophylaxis and/or treatment of certain diseases | |
| EP0459176A3 (en) | Oligophosphates with antiviral activity | |
| ITMI931393A0 (it) | Procedimento per il funzionamento di un filtro elettrostatico nonche' filtro elettrostatico per l'attuazione del procedimento | |
| ES2133573T3 (es) | Analogos antiviricos de difluoro estatone. | |
| IT8223437A0 (it) | Apparecchiatura ad arco-plasma perl'applicazione di rivestimenti. | |
| IT7823549A0 (it) | Composto di pentapeptide adattivita' analgesica. | |
| IT8024347A0 (it) | L'applicazione di 4-arilchinazolin-2(1h)-oni per il trattamento delle malattie autoimmuni dei tessuti connettivi. | |
| IT8221325A0 (it) | Procedimento per la depurazione dell'aria e per il recupero diretto di vapori di solventi e apparecchiatura relativa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 646376 Country of ref document: ES |